# Investigation of Cycloserine as a Smoking Cessation Treatment

> **NCT01062932** · PHASE1 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 34 (actual)

## Conditions studied

- Nicotine Addiction

## Interventions

- **DRUG:** Cycloserine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01062932
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-05
- **Final completion:** 2010-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2012-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01062932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01062932, "Investigation of Cycloserine as a Smoking Cessation Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01062932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
